Stock listing
OTC:ONPH Oncology Pharma Inc. Stock
Follow Oncology Pharma Inc. into a list and get an email when it puts out news.
Share price · OTC:ONPH
$0.037 USD -0.004 (-8.6%)
Close on Nov 20, 2026
- Day range
- $0.037 – $0.050 USDNov 20, 2026
- Volume
- 8,534 sharesNov 20, 2026
- Market cap
- $3.04M USDAt the close on Nov 20, 2026 · price × 82.16M shares outstanding
- 52-week range
- $0.0009 – $0.364 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $618 USDMedian day 7,661 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OTC:ONPH · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.037 | -0.004 | -8.6% | $0.037 | $0.050 | $0.037 | 8,534 | |
| $0.041 | +0.004 | +9.5% | $0.037 | $0.041 | $0.037 | 9,604 | |
| $0.037 | -0.004 | -8.6% | $0.037 | $0.049 | $0.037 | 9,645 | |
| $0.041 | +0.005 | +12.5% | $0.036 | $0.041 | $0.036 | 3,037 | |
| $0.036 | -0.008 | -18.2% | $0.040 | $0.045 | $0.036 | 125,258 | |
| $0.044 | +0.004 | +10.0% | $0.044 | $0.044 | $0.040 | 5,334 | |
| $0.040 | 0.000 | 0.0% | $0.040 | $0.040 | $0.040 | 3,701 | |
| $0.040 | 0.000 | 0.0% | $0.040 | $0.050 | $0.040 | 27,631 | |
| $0.040 | 0.000 | 0.0% | $0.052 | $0.052 | $0.040 | 8,490 | |
| $0.040 | -0.005 | -11.1% | $0.040 | $0.050 | $0.040 | 6,220 | |
| $0.045 | +0.005 | +12.5% | $0.040 | $0.050 | $0.040 | 16,326 | |
| $0.040 | 0.000 | 0.0% | $0.040 | $0.050 | $0.040 | 3,901 | |
| $0.040 | -0.008 | -16.5% | $0.040 | $0.052 | $0.040 | 48,731 | |
| $0.048 | +0.008 | +19.7% | $0.046 | $0.048 | $0.040 | 8,159 | |
| $0.040 | +0.004 | +11.1% | $0.040 | $0.048 | $0.030 | 13,520 | |
| $0.036 | +0.006 | +19.6% | $0.031 | $0.036 | $0.031 | 2,023 | |
| $0.030 | -0.016 | -34.6% | $0.030 | $0.035 | $0.030 | 7,383 | |
| $0.046 | -0.002 | -4.2% | $0.030 | $0.046 | $0.030 | 8,590 | |
| $0.048 | 0.000 | 0.0% | $0.035 | $0.048 | $0.035 | 8,765 | |
| $0.048 | +0.013 | +37.1% | $0.048 | $0.048 | $0.036 | 17,268 | |
| $0.035 | 0.000 | 0.0% | $0.041 | $0.048 | $0.033 | 2,653 | |
| $0.035 | +0.004 | +13.6% | $0.035 | $0.052 | $0.033 | 3,283 | |
| $0.031 | -0.010 | -24.3% | $0.041 | $0.041 | $0.031 | 1,445 | |
| $0.041 | -0.011 | -21.7% | $0.041 | $0.052 | $0.041 | 5,543 | |
| $0.052 | -0.004 | -7.0% | $0.031 | $0.052 | $0.030 | 7,953 | |
| $0.056 | -0.004 | -6.1% | $0.030 | $0.060 | $0.030 | 36,293 | |
| $0.060 | +0.009 | +19.0% | $0.030 | $0.060 | $0.030 | 3,669 | |
| $0.050 | +0.020 | +66.1% | $0.030 | $0.054 | $0.030 | 8,709 | |
| $0.030 | -0.020 | -39.8% | $0.050 | $0.055 | $0.030 | 15,611 | |
| $0.050 | +0.020 | +66.7% | $0.030 | $0.060 | $0.030 | 7,071 | |
| $0.030 | -0.020 | -39.4% | $0.030 | $0.045 | $0.030 | 6,650 | |
| $0.050 | +0.020 | +65.0% | $0.030 | $0.050 | $0.030 | 4,193 | |
| $0.030 | -0.024 | -44.9% | $0.030 | $0.054 | $0.030 | 15,879 | |
| $0.054 | -0.006 | -9.3% | $0.052 | $0.054 | $0.030 | 21,058 | |
| $0.060 | +0.016 | +35.4% | $0.030 | $0.062 | $0.030 | 15,217 | |
| $0.044 | +0.010 | +30.3% | $0.045 | $0.045 | $0.044 | 5,724 | |
| $0.034 | -0.028 | -45.2% | $0.062 | $0.062 | $0.034 | 23,376 | |
| $0.062 | -0.003 | -4.5% | $0.030 | $0.062 | $0.030 | 2,644 | |
| $0.065 | +0.025 | +62.2% | $0.068 | $0.068 | $0.031 | 7,661 | |
| $0.040 | -0.010 | -20.0% | $0.050 | $0.050 | $0.040 | 24,957 | |
| $0.050 | -0.001 | -2.0% | $0.050 | $0.059 | $0.050 | 12,875 | |
| $0.051 | +0.001 | +2.0% | $0.064 | $0.068 | $0.050 | 6,130 | |
| $0.050 | -0.002 | -3.8% | $0.052 | $0.064 | $0.020 | 125,795 | |
| $0.052 | 0.000 | -0.2% | $0.069 | $0.069 | $0.052 | 7,783 | |
| $0.052 | 0.000 | 0.0% | $0.052 | $0.052 | $0.052 | 608 | |
| $0.052 | -0.016 | -23.4% | $0.052 | $0.052 | $0.052 | 1,118 | |
| $0.068 | +0.017 | +32.8% | $0.052 | $0.068 | $0.052 | 3,140 | |
| $0.051 | +0.000 | +0.4% | $0.051 | $0.069 | $0.051 | 27,274 | |
| $0.051 | 0.000 | -0.8% | $0.069 | $0.069 | $0.051 | 13,840 | |
| $0.051 | +0.000 | +0.4% | $0.051 | $0.065 | $0.051 | 5,107 | |
| $0.051 | -0.014 | -21.2% | $0.069 | $0.069 | $0.051 | 4,410 | |
| $0.065 | +0.000 | +0.2% | $0.054 | $0.069 | $0.051 | 4,609 | |
| $0.065 | 0.000 | -0.2% | $0.050 | $0.065 | $0.050 | 5,146 | |
| $0.065 | +0.000 | +0.2% | $0.050 | $0.069 | $0.050 | 10,553 | |
| $0.065 | -0.003 | -4.4% | $0.068 | $0.068 | $0.051 | 8,898 | |
| $0.068 | +0.013 | +23.5% | $0.050 | $0.068 | $0.050 | 20,609 | |
| $0.055 | +0.003 | +5.8% | $0.069 | $0.069 | $0.051 | 14,974 | |
| $0.052 | 0.000 | -0.6% | $0.050 | $0.069 | $0.050 | 5,848 | |
| $0.052 | +0.001 | +2.5% | $0.060 | $0.060 | $0.051 | 3,391 | |
| $0.051 | 0.000 | 0.0% | $0.051 | $0.051 | $0.051 | 513 | |
| $0.051 | 0.000 | 0.0% | $0.051 | $0.051 | $0.051 | 6,354 | |
| $0.051 | -0.001 | -2.5% | $0.051 | $0.051 | $0.051 | 2,963 | |
| $0.052 | +0.001 | +2.5% | $0.051 | $0.069 | $0.051 | 11,768 | |
| $0.051 | -0.001 | -2.5% | $0.069 | $0.069 | $0.051 | 1,089 | |
| $0.052 | +0.001 | +2.5% | $0.052 | $0.052 | $0.051 | 5,991 |
Splits
4 splits since 1999 · OTC:ONPH · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-100 | Consolidation | |
| 1-for-10000 | Consolidation | |
| 1-for-500 | Consolidation | |
| 1-for-4 | Consolidation |
- Ticker
- OTC:ONPH
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- OTC
- Currency
- USD
Latest news
Oncology Pharma Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 115 in all · newest Jul 12, 2022 · oldest 2012
Valuation
Statements: Year to Mar 31, 2026 · price Nov 20, 2026
- Enterprise value
- Not reported
- P/E
- Loss
- EV/sales
- No revenue
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- Not reported
- Gross margin
- No revenue
- Operating margin
- No revenue
- Net margin
- No revenue
- Debt to equity
- Not reported
- Beta vs S&P 500
- 1.62
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Oncology Pharma Inc. · OTC:ONPH | US$3.04M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.62 |
| Spago Nanomedical AB · OMXSTO:SPAGO | US$3.20M | US$22,063 | n/a | 5.6× | n/a | 1.0× | n/a | 0.0× | n/a |
| Kiora Pharmaceuticals, Inc. · NASDAQ:KPRX | US$3.19M | −US$12.81M | n/a | −12.8× | n/a | 0.2× | n/a | 0.0× | 1.54 |
| Azitra Inc · AMEX:AZTR | US$3.13M | −US$618,677 | n/a | n/a | n/a | 0.7× | n/a | 0.0× | 0.60 |
| NuCana plc · NASDAQ:NCNA | US$3.12M | −US$21.37M | n/a | n/a | n/a | 0.1× | n/a | 0.0× | 1.58 |
| Revive Therapeutics Ltd. · CSE:RVV | US$3.10M | US$3.14M | n/a | n/a | n/a | n/a | n/a | n/a | 0.56 |
| Skye Bioscience, Inc. · NASDAQ:SKYE | US$3.10M | −US$1.71M | n/a | n/a | n/a | 2.3× | n/a | 0.0× | 0.85 |
| Creative Medical Technology Holdings, Inc. · NASDAQ:CELZ | US$3.06M | −US$3.79M | n/a | −1,263× | n/a | 0.4× | n/a | 0.0× | 1.53 |
| Imunon, Inc. · NASDAQ:IMNN | US$3.00M | US$5.90M | n/a | n/a | n/a | 1.1× | n/a | 2.6× | 0.57 |
| Gelteq Limited · NASDAQ:GELS | US$2.89M | US$6.27M | n/a | 57.2× | n/a | 0.3× | n/a | 0.4× | 0.83 |
| Curis, Inc. · NASDAQ:CRIS | US$2.85M | −US$1.42M | n/a | n/a | n/a | 1.1× | n/a | 0.3× | 1.85 |
| Median of the others | US$3.10M | −US$1.02M | −3.6× | 0.7× | 0.0× | 0.85 |
Financials
Annual, in USD
Income statement
| Line | FY2026 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2013 | FY2011 | FY2004 | FY2003 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10.2K | 134.7K | 1.18M | 3.28M | ||||||
| Cost of revenue | 779 | 1.11K | 1.11K | 654.0K | 1.21M | |||||
| Gross profit | -779 | -1.11K | -1.11K | 10.2K | 134.7K | 527.0K | 2.07M | |||
| Research and development | 376.0K | 780.0K | ||||||||
| Selling, general and administrative | 18.9K | 19.2K | 1.85M | 2.91M | ||||||
| Operating income | -5.82K | -62.0K | -14.4M | -403.9K | -818.9K | -14.5K | 59.5K | -1.70M | -1.63M | |
| Depreciation and amortization | 228.5K | 236.6K | 779 | 1.11K | 1.11K | 5.82K | 5.82K | 81.0K | 395.0K | |
| EBITDA | 174.5K | -14.4M | -402.8K | -817.8K | -8.65K | 65.3K | -1.62M | -1.23M | ||
| Interest expense | 104.6M | 82.8M | 25.0K | 31.5K | 0 | 0 | 0 | 0 | ||
| Income before tax | -5.82K | -104.6M | -97.5M | -207.6K | -850.4K | -14.5K | 59.5K | -1.57M | -1.54M | |
| Income tax | -236.6K | 3.49K | 1 | 1 | 800 | 800 | -136.0K | -105.0K | ||
| Net income | -5.82K | -104.6M | -97.5M | -207.6K | -850.4K | 186.0K | 58.7K | -1.56M | -1.52M | |
| Earnings per share, basic | -0.00 | -3.42 | -6.76 | -0.12 | -0.72 |
Balance sheet
| Line | FY2026 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2013 | FY2011 | FY2004 | FY2003 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 3.96K | 8.95K | 1.80K | 6.71K | 9.31K | 8.00K | 1.35M | |||
| Receivables | 15.0K | 19.0K | 19.0K | |||||||
| Inventory | 177.6K | 150.2K | ||||||||
| Current assets | 3.96K | 8.95K | 1.80K | 6.71K | 186.9K | 165.2K | 48.0K | 1.58M | ||
| Property, plant and equipment | 6.32K | 62.0K | 129.0K | |||||||
| Total assets | 2.12M | 347.6K | 230.9K | 190.5K | 198.6K | 262.2K | 48.0K | 1.75M | ||
| Accounts payable | 7.16K | 10.8K | 195.0K | 195.0K | ||||||
| Current liabilities | 875.5K | 517.6K | 294.5K | 403.2K | 213.0K | 666.4K | 220.0K | 879.0K | ||
| Long-term debt | 205.9K | |||||||||
| Total debt | 662.1K | 238.4K | 129.4K | 238.1K | 25.0K | |||||
| Total liabilities | 875.5K | 517.6K | 294.5K | 403.2K | 418.9K | 666.4K | 220.0K | 879.0K | ||
| Shareholders' equity | 1.25M | -170.0K | -63.7K | -212.6K | -220.3K | -404.3K | -172.0K | 872.0K | ||
| Shares outstanding | 82.2M | 38.6M | 30.6M | 14.4M | 1.68M | 1.19M | 2 | 1 |
Cash flow
| Line | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2013 | FY2011 | FY2004 | FY2003 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 368.6K | -117.1K | -22.4K | -36.9K | 7.06K | 7.06K | -2.00M | -1.44M | |
| Capital spending | 0 | 0 | -4 | 0 | 0 | -6.32K | -6.32K | -17.0K | -147.0K |
| Free cash flow | 368.6K | -117.1K | -22.4K | -36.9K | 740 | 740 | -2.02M | -1.59M | |
| Cash from investing | -1.78M | -321.9K | 186.5K | 186.5K | 116.0K | -145.0K | |||
| Cash from financing | 1.41M | 446.2K | 17.5K | 42.9K | 205.9K | 205.9K | 546.0K | 1.00K | |
| Change in cash | -4.99K | 7.15K | -4.90K | 5.98K | 12.4K | 12.4K | -1.34M | -1.59M |
Cap table
Built by 6ix from Oncology Pharma Inc.’s releases
- Common shares
- 82,164,642
- Fully diluted
- 82,164,642
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 82,164,642 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 82,164,642 |
Log in to ask 6ix AI your own questions about Oncology Pharma Inc.